34 ANALYTICAL AND LABORATORY EQUIPMENT
LIMS market expected to reach US$1.3m by 2019
The global Laboratory Information Management Systems (LIMS) market is expected to reach US$1.323 million by 2019 from US$848.5 million in 2014, growing at a CAGR of 9.3%. This is according to work by researcher Markets and Markets. Major factors driving the growth
of this market include rising pressure to comply with regulations, trend of replacement of legacy systems with commercial off-the-shelf (COTS) LIMS solutions, growth in biobanks/ biorepositories, growing need to integrate healthcare systems, and a rise in awareness of technological advancements in LIMS. On the other hand, the high cost of
maintenance and services and the lack of trained HCIT professionals may hinder the growth of this market. In 2014, North America dominated the LIMS market with the US accounting
for a major share. However, Asia is poised to grow at the highest CAGR during the forecast period owing to increasing outsourcing of activities by European and North American pharmaceutical companies in this region, which will require better laboratory workflow management and regulatory compliance. Furthermore, the increasing number of clinical trials in emerging economies such as China, India and Singapore; rising government initiatives for R&D activities; and lower labour costs are some of the major factors likely to drive the growth of LIMS in Asian market. Meanwhile, the global lab
automation market is poised to reach US$5.105 million by 2020 from US$3.474 million in 2014, at a CAGR of 6.7% from 2015 to 2020. In this report, the global lab
automation market is segmented on Meeting media formulation standards
Industry standard ISO 11133:2014 relates to the microbiology of food, animal feed and water – culture media preparation, production, storage and testing. The new ISO 11133:2014 standard was published in May 2014 and replaces the previous standards EN ISO TS 11133-1:2009 and EN ISO TS 11133-2:2003, which separately covered preparation of culture media and performance testing of culture media. The ISO 11133:2014 standard applies to all types of media formulation, including dehydrated culture media (DCM) and ready-prepared media that are used for all applications – whether these are conventional culture or rapid methods. Since March 2015, Lab M has been compliant according to ISO 11133:2014. In addition, the QC
laboratory at Lab M is working towards ISO 17025, with UKAS accreditation anticipated in the coming months. Each batch of Lab M media is appropriately
tested using the specific test strain named in the standard. ISO 11133:2014 ensures the improvement to consumer safety in food and beverage products and that performance should imitate the intended sample testing conditions. Lab M is also working towards ISO 17025 to
demonstrate compliance with the relevant standard for the quality control testing of Pinnacle pre-poured plates, using the company’s own dehydrated culture media (DCM). This includes the extension of the existing quality management system for quality control testing and adherence to rigorous technical requirements. This means Pinnacle plates can be relied on without the need to perform any supplementary QC tests of their own. Lab M has produced a white paper on the new International Standard ISO 11133:2014 detailing the requirements of the standard and explaining the steps taken by Lab M to ensure compliance.
Lab M demonstrates quality with compliance to ISO 11133:2014.
www.scientistlive.com
For more information, visit
www.labm.com
the basis of equipment and software, application, type of automation, end user and region. Based on equipment and software,
this market is segmented into six broad categories: automated liquid handling, microplate readers, standalone robots, automated storage and retrieval systems (ASRS), software and informatics, and others (barcode readers, weighing platforms, microplate coolers, and tube recognition devices). In 2014, the automated liquid handling segment accounted for the largest share of the lab automation market, by equipment and software. On the basis of type of automation,
the lab automation market is segmented into modular automation and total lab automation (TLA). The modular automation segment accounted for the largest share of the this market as modular automation
is affordable to almost all small-to- medium-sized labs and requires less space. Factors such as miniaturisation,
progressing drug discovery and clinical diagnostics, higher reproducibility and accuracy, and large workforce demand and supply gap are driving the growth.
In addition, greater productivity
and reduction in costs, better personnel safety, and requirement of small volumes of samples and reagents are boosting market growth. Emerging markets such as Brazil, China, India and the Middle East provide new growth opportunities. However, the lack of planning for technology development and indefinite data interchange are restricting market growth.
For more information, visit
www.marketsandmarkets.com Arterial blood gas analyser
Sphere Medical has added new functionality to its Proxima patient dedicated arterial blood gas analyser to allow direct connectivity to hospital information systems. This is crucial in the efficient management of patient data generated by the Proxima system and enables Point-of-Care Coordinators and other laboratory staff to remotely monitor the use and performance of this new analytical in-line system being used directly at the patient’s bedside. The new enhancement ensures that all patient test
data for blood gas and electrolyte measurements, as well as system quality control data, can be transferred through an Ethernet connection to the hospital information network. This direct data transfer uses the standard HL7
communication protocol format that is easily integrated into information management systems, such as the Laboratory Information System and electronic Patient Data Management Systems. The CE marked Proxima supports proactive patient
care, particularly at critical times, since it enables rapid and frequent measurement without leaving the patient. This is possible as the Proxima sensor is a miniaturised version of a blood gas analyser that is integrated directly into the patient’s arterial line, meaning that all blood is returned to the patient.
For more information, visit
www.spheremedical.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92